Tech Company Financing Transactions
Mironid Funding Round
Mironid, based in Glasgow, Scotland, secured $43.4 million from Roche Venture Fund, BioGeneration Ventures and Epidarex Capital.
Transaction Overview
Company Name
Announced On
9/13/2023
Transaction Type
Venture Equity
Amount
$43,351,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to progress its lead discovery programme through IND-enabling studies and to extend its patent estate.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Arbuthnott Building -- Hamnett Wing, 161 Cathedral Street
Glasgow, Scotland, G4 0RE
UK
Glasgow, Scotland, G4 0RE
UK
Phone
Undisclosed
Website
Email Address
Overview
Mironid is a vibrant, growing, patient focused company with an outstanding team motivated to deliver innovative new medicines. We aim to improve the health and quality of life of patients by creating high value therapeutics addressing global unmet medical needs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Wilkie
Browse more venture capital transactions:
Prev: 9/13/2023: Deduce venture capital transaction
Next: 9/13/2023: Science On Call venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs